Ms. Anne E. Tierney, CRNA Nurse Anesthetist, Certified Registered Medicare: Accepting Medicare Assignments Practice Location: 4 Diana Dr, Pawtucket, RI 02861 Phone: 401-723-5568 |
Mr. Richard Donald Del Sesto, CRNA Nurse Anesthetist, Certified Registered Medicare: Accepting Medicare Assignments Practice Location: 188 Oak Hill Ave, Pawtucket, RI 02860 Phone: 401-787-6949 Fax: 401-723-7005 |
Mr. Mark Allen Foster, CRNA Nurse Anesthetist, Certified Registered Medicare: Accepting Medicare Assignments Practice Location: 111 Brewster St, Pawtucket, RI 02860 Phone: 401-729-2431 Fax: 401-729-3476 |
Mrs. Kim M Foote, CRNA Nurse Anesthetist, Certified Registered Medicare: Accepting Medicare Assignments Practice Location: 111 Brewster St, Pawtucket, RI 02860 Phone: 401-729-2435 Fax: 401-729-3476 |
News Archive
Eisai Co., Ltd. has entered into an agreement to grant exclusive development and marketing rights for its anti-obesity agent lorcaserin hydrochloride in Brazil to Eurofarma Laboratorios S.A. Under this agreement, Eisai will supply Eurofarma with lorcaserin. Eisai will receive a one-time contractual payment and is eligible for milestone payments for sales in Brazil.
An international, multidisciplinary research team from more than 50 institutions, led by geneticist and psychiatrist Gholson Lyon, MD, PhD, of the New York State Office for People With Developmental Disabilities' Institute for Basic Research in Developmental Disabilities, today announced publication of findings from its study of the rare disease TAF1 syndrome.
A research team has tested the utility of the short version of WHO-DAS II, a tool to assess within five minutes disability in patients with depression, "which in the case of primary care is even more practicable than the long version of the instrument." In Spain, more than 10% of the population suffer from severe depression.
Epitomics, Inc. announced today that it has signed a service agreement with Bayer Schering Pharma AG, Germany.
The Cancer Prevention and Research Institute of Texas (CPRIT) awarded on January 20th the first $61 million in grants for cancer research projects at academic institutions and private companies throughout Texas. These are the inaugural grants of the $3 billion to be invested in cancer research in Texas over the next ten years.
› Verified 7 days ago